Skip to main content

Applied Therapeutics, Inc. (APLT) Stock

Applied Therapeutics, Inc. Stock Details, Movements and Public Alerts

Stock Details

Applied Therapeutics, Inc. (APLT), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NGM.Currently, the stock is trading at $0.10. Over the past 52 weeks, it has ranged between $0.09 and $1.50. This places the current price at 6.7% of its 52-week high and 11.1% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 35.56, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.10 by 0.00%. Similarly, it is below its 200-day moving average of $0.42 by 76.19%. The MACD histogram is 0.00, indicating neutral momentum0. There is currently 1 active alert set for APLT by users.

52-Week Range

$1.50 - $0.09

-93.33% from high · +11.11% from low

Avg Daily Volume

N/A

100-day average

0

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-0.26

EV/EBITDA

-0.05

EPS (TTM)

-$0.10

Price to Sales

14.86

Beta

2.08

More volatile than market

Q:How is APLT valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is APLT's risk profile compared to the market?
With a beta of 2.08, Applied Therapeutics, Inc. is significantly more volatile than the market. For every 10% market move, this stock tends to move 21% in the same direction. Higher beta stocks offer greater potential returns but with increased risk.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-1796.70%

EBITDA

$-99,611,000

Return on Equity

-680.47%

Return on Assets

-88.35%

Revenue Growth (YoY)

719.70%

Q:How profitable and efficient is APLT's business model?
0 The operating margin of -1796.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -680.47% and ROA at -88.35%, the company achieves moderate returns on invested capital.
Q:What are APLT's recent growth trends?
Applied Therapeutics, Inc.'s revenue grew by 719.70% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$14.9M

Revenue (TTM)

$1.00M

Revenue/Share (TTM)

$0.01

Shares Outstanding

144.30M

Book Value/Share

-$0.00

Asset Type

EQUITY

Q:What is APLT's market capitalization and position?
Applied Therapeutics, Inc. has a market capitalization of $14.9M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 144.30M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does APLT's price compare to its book value?
Applied Therapeutics, Inc.'s book value per share is -$0.00, while the current stock price is $0.10, resulting in a price-to-book (P/B) ratio of -25.00. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Recommendations

Strong Buy

0

Buy

2

Hold

2

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for APLT?
4 analysts cover APLT with 50% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook.
Q:What is the Wall Street consensus on APLT?
Current analyst recommendations:02 Buy, 2 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 13, 2026, 02:02 AM

Technical Indicators

RSI (14-day)

35.56

Neutral

50-Day Moving Average

$0.10

0.00% below MA-50

200-Day Moving Average

$0.42

-76.19% below MA-200

MACD Line

N/A

MACD Signal

N/A

MACD Histogram

N/A

Neutral

Q:What does APLT's RSI value tell investors?
The RSI (Relative Strength Index) for APLT is currently 35.56, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret APLT's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.00 below the signal line at 0.00, with histogram at 0.00. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.10) is below the 200-day MA ($0.42), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 13, 2026, 01:01 AM

Active Alerts

Alert Condition
Price increases by
Threshold
25%
Created
Nov 19, 2025, 01:03 PM

Stay Ahead of the Market with Applied Therapeutics, Inc. Alerts

Set up price alerts for Applied Therapeutics, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.